sativex

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

Abstract Adults with ADHD describe self-medicating with cannabis, with some reporting a preference for cannabis over ADHD medications. A small number of psychiatrists in the US prescribe cannabis medication for ADHD, despite there being no evidence from randomised controlled studies. The EMA-C trial (Experimental Medicine in ADHD-Cannabinoids) was a pilot randomised placebo-controlled experimental study of …

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. Read More »

Sep 24 2019

Cannabinoids for Treatment of MS Symptoms: State of the Evidence.

ABSTRACT Two recent high-quality systematic reviews concluded that the only strong evidence for medical marijuana in neurological disorders was for reducing the symptoms of patient-reported spasticity and central pain in MS and that the only complementary and alternative medicine (CAM) intervention in MS with strong supportive evidence was cannabinoids. Based on this review, they concluded …

Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Read More »

Aug 25 2019

JOIN OUR NEWSLETTER

Be the first to receive exciting news, features, and special offers from MCBDshop.com

MCBD is an organic line of CBD wellness products made with the highest quality hemp CBD on the market. Our full spectrum hemp cbd oil is naturally thc-free, premium grade and Farm Bill compliant. Our full spectrum CBD products are thc-free, organic, all-natural and formulated with our patented nanoemulsification technology making our cbd products more effective.

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

Cannabinoids for Treatment of MS Symptoms: State of the Evidence.

JOIN OUR NEWSLETTER

CONNECT WITH US

About

LEARN

Shop

These statements have not been evaluated by the FDA. This product is not intended diagnose, treat, cure or prevent disease.